Stockholder’s Equity (Deficit) (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
1 Months Ended |
2 Months Ended |
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
|
|
|
|
|
Feb. 26, 2026 |
Jan. 28, 2026 |
Nov. 30, 2025 |
Oct. 09, 2025 |
Aug. 09, 2025 |
Aug. 01, 2025 |
Jul. 16, 2025 |
Sep. 02, 2025 |
Jul. 25, 2025 |
Mar. 12, 2026 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Mar. 31, 2026 |
Mar. 31, 2025 |
Sep. 30, 2025 |
Jan. 04, 2026 |
Aug. 06, 2025 |
Aug. 04, 2025 |
Jul. 14, 2025 |
May 22, 2025 |
Apr. 28, 2025 |
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
10,000,000
|
|
10,000,000
|
|
10,000,000
|
|
|
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
$ 0.01
|
|
$ 0.01
|
|
|
|
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
0
|
|
0
|
|
0
|
|
|
|
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
0
|
|
0
|
|
0
|
|
|
|
|
|
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
150,000,000
|
|
150,000,000
|
|
150,000,000
|
|
|
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
$ 0.01
|
|
$ 0.01
|
|
|
|
|
|
|
| Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
20,347,137
|
|
20,347,137
|
|
14,521,094
|
|
|
|
|
|
|
| Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
20,347,137
|
|
20,347,137
|
|
14,521,094
|
|
|
|
|
|
|
| Class of Warrant or Right, Unissued |
|
|
|
|
|
|
|
|
|
|
6,900,000
|
|
6,900,000
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights |
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
$ 0.01
|
|
|
|
|
|
|
|
|
| Sale of Stock, Price Per Share |
|
|
|
|
|
|
|
|
|
|
$ 18.00
|
|
$ 18.00
|
|
|
|
|
|
|
|
$ 0.001
|
| Exercise of warrants, share |
|
|
|
|
|
|
|
|
|
|
46,747
|
|
542,256
|
|
|
|
|
|
|
|
|
| Exercise of warrant |
|
|
|
|
|
|
|
|
|
|
$ 537,591
|
|
$ 6,235,945
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Outstanding |
|
|
|
|
|
|
|
|
|
|
8,396,069
|
|
8,396,069
|
|
7,304,992
|
|
|
|
|
|
|
| Shares, Issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
280,534
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross |
|
|
|
|
|
|
500,000
|
|
|
|
|
|
6,350,000
|
|
|
|
|
|
|
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period |
|
|
|
|
|
|
|
|
|
4 years
|
|
|
4 years
|
|
|
|
|
|
|
|
|
| Granted share option |
|
|
$ 30,000
|
|
|
$ 60,000
|
|
$ 500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General and Administrative Expense |
|
|
|
|
|
|
|
|
|
|
$ 2,922,318
|
$ 131,463
|
$ 7,602,857
|
$ 275,231
|
|
|
|
|
|
|
|
| Intrinsic value of outstanding options |
|
|
|
|
|
|
|
|
|
|
$ 735,000
|
|
$ 735,000
|
|
$ 14,429,000
|
|
|
|
|
|
|
| Vested and exercisable |
|
|
|
|
|
|
|
|
|
|
500,000
|
|
500,000
|
|
500,000
|
|
|
|
|
|
|
| Employee Benefits and Share-Based Compensation |
|
|
|
|
|
|
|
|
|
|
$ 143,221
|
0
|
$ 188,221
|
0
|
|
|
|
|
|
|
|
| Deferred Compensation Equity |
|
|
|
|
|
|
|
|
|
|
146,840
|
|
146,840
|
|
$ 150,000
|
|
|
|
|
|
|
| Issuance Of Shares To Former Directors Description |
|
|
|
|
On August 9, 2025, the Company entered into compensation agreements with
three former directors, pursuant to which each director will receive $120,000 payable in cash or shares. Two directors elected to receive
a total of $125,000 in shares and on September 10, 2025, total shares of 10,927 were issued and stock-based compensation of $125,000 related
the compensation agreements with two former directors was included in general and administrative expense on the consolidated statements
of operations during the year ended September 30, 2025. There was no issuance of shares for the three and six months ended March 31, 2026.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock share issued |
|
|
|
|
|
|
|
|
200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock Fair Value Issued |
$ 6,986,665
|
|
|
|
|
|
|
|
|
|
|
|
470,000
|
|
|
|
|
|
|
|
|
| Stock Issued During Period, Shares, Issued for Services |
|
|
|
|
|
|
|
|
22,500
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued to directors |
|
|
|
|
|
|
|
|
|
|
$ 25,000
|
|
25,000
|
|
0
|
|
|
|
|
|
|
| RSUs stock based compensation |
|
|
|
$ 75,000
|
|
|
|
|
|
|
|
|
218,221
|
|
|
|
|
|
|
|
|
| Equity component value |
|
|
|
|
|
|
|
|
|
|
|
|
$ 350,000
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
|
|
|
35,000
|
|
35,000
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
|
$ 10.00
|
|
$ 10.00
|
|
|
|
|
|
|
|
|
| Stock-based compensation liability |
|
|
|
|
|
|
|
|
|
|
|
|
$ 350,000
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares in asset acquisition, shares |
|
8,532
|
|
|
|
|
|
|
|
|
|
|
1,500,000
|
|
|
|
|
|
|
|
|
| Public Rights [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Preferred Stock, Shares Issued upon Conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,900,000
|
|
|
| Private Rights [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Preferred Stock, Shares Issued upon Conversion |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
406,000
|
|
|
| Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Intrinsic value |
|
|
|
|
|
|
|
|
|
|
$ 1,419,000
|
|
$ 1,419,000
|
|
0
|
|
|
|
|
|
|
| Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Unissued |
|
|
|
|
|
|
|
|
|
|
406,000
|
|
406,000
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights |
|
|
|
|
|
|
|
|
|
|
$ 11.50
|
|
$ 11.50
|
|
|
|
|
|
|
|
|
| IPO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Unissued |
|
|
|
|
|
|
|
|
|
|
6,900,000
|
|
6,900,000
|
|
|
|
|
|
|
|
|
| Board Of Directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.01
|
|
|
|
| Shares, Issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,000,000
|
|
|
|
| Equity Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subsidiary, Sale of Stock [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Exercise Price of Warrants or Rights |
|
|
|
|
|
|
$ 3.27
|
|
|
$ 7.47
|
$ 9.09
|
|
$ 9.09
|
|
|
$ 9.26
|
$ 7.2
|
|
|
|
|
| General and Administrative Expense |
|
|
|
|
|
|
|
|
|
|
$ 1,119,097
|
$ 0
|
$ 3,128,944
|
$ 0
|
|
|
|
|
|
|
|
| compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,452,240
|
|
|
|
|
|
|